Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Protein Sciences develops emergency vaccine against Hong Kong influenza

Feb. 9, 1998

Cytel and Baxter extend xenotransplantation agreement

Feb. 5, 1998

CBER completes review of Thymoglobulin PLA

Feb. 2, 1998

OspC-based Lyme disease vaccine proves effective in animal model of chronic disease

Feb. 2, 1998

Aquila receives milestone payment from SKB under Stimulon agreement

Jan. 30, 1998

Another SMART antibody advances to clinical testing

Jan. 30, 1998

Positive U.S. phase II results for Thymoglobulin in preventing kidney transplant rejection

Jan. 28, 1998

Chesapeake Biological Laboratories and LXR to codevelop Cardiosol products

Jan. 27, 1998

Nabi's Altastaph enters phase I/II

Jan. 26, 1998

Quilimmune-P enters phase II

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...